Literature DB >> 2744336

Post-transfusion hepatitis type B: long incubation period and poor prognosis in compromised hosts.

K Inoue1, T Konda, K Takashima, Y Kuwabara, H Sasaki.   

Abstract

Seven cases of post-transfusion hepatitis type B [PTH(B)] were investigated. PTH(B) developed in 4 patients more than 65 years old and in 4 patients after treatment of a malignant disease (2 cases of gastric cancer and one each of ovarian cancer and chronic myelogenous leukemia, respectively). The mean incubation period was 78 days (70-90) in patients with non-malignant diseases and 147 days (105-200) in patients with malignant diseases. The symptoms of acute hepatic failure developed in 6 patients and 5 of them expired. One fatal case revealed 4 units of blood and an investigation of 4 donors revealed that one of them was an HBsAg carrier with negative serum HBsAg by the reverse passive hemagglutination (RPHA) method. From these results, it was concluded that compromised hosts such as aged patients or patients with malignant diseases are apt to contract severe PTH(B) with a long incubation period when the transfused blood contains small amounts of HBV.

Entities:  

Mesh:

Year:  1989        PMID: 2744336     DOI: 10.1007/bf02774197

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  18 in total

1.  RISK OF POST-TRANSFUSION VIRAL HEPATITIS.

Authors:  G F GRADY; T C CHALMERS
Journal:  N Engl J Med       Date:  1964-08-13       Impact factor: 91.245

2.  The course of infectious hepatitis at varying ages and its spread among different social groups (Stockholm 1948-49).

Authors:  H MANNBECK
Journal:  Acta Med Scand       Date:  1956-10-15

3.  Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

Authors:  J H Hoofnagle; R J Gerety; L Y Ni; L F Barker
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

4.  Viral hepatitis in the elderly. An analysis of 23 patients over 65 years of age.

Authors:  L F Fenster
Journal:  Gastroenterology       Date:  1965-09       Impact factor: 22.682

5.  Viral hepatitis: report on WHO informal consultation.

Authors:  R W McCollum; A J Zuckerman
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

6.  Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors.

Authors:  H J Alter; P V Holland; R H Purcell; J J Lander; S M Feinstone; A G Morrow; P J Schmidt
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

7.  Va cooperative study of post-transfusion hepatitis, 1969-1974: incidence and characteristics of hepatitis and responsible risk factors.

Authors:  L B Seeff; E C Wright; H J Zimmerman; R W McCollum
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

8.  Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.

Authors:  J H Hoofnagle; L B Seeff; Z B Bales; H J Zimmerman
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

9.  Reactivation of chronic hepatitis B virus infection by cancer chemotherapy.

Authors:  J H Hoofnagle; G M Dusheiko; D F Schafer; E A Jones; K C Micetich; R C Young; J Costa
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

10.  Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis.

Authors:  M Shimizu; M Ohyama; Y Takahashi; K Udo; M Kojima; M Kametani; F Tsuda; E Takai; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.